國立虎尾科技大學 |

Cardiovascular Complications in Cancer Therapy

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Cardiovascular Complications in Cancer Therapy/ edited by Antonio Russo, Giuseppina Novo, Patrizio Lancellotti, Antonio Giordano, Fausto J. Pinto.
其他作者:	Russo, Antonio.
面頁冊數:	XIII, 224 p. 41 illus., 38 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-93402-0
ISBN:	9783319934020

Cardiovascular Complications in Cancer Therapy
Cardiovascular Complications in Cancer Therapy[electronic resource] /edited by Antonio Russo, Giuseppina Novo, Patrizio Lancellotti, Antonio Giordano, Fausto J. Pinto. - 1st ed. 2019. - XIII, 224 p. 41 illus., 38 illus. in color.online resource. - Current Clinical Pathology,2197-781X. - Current Clinical Pathology,.

Introduction -- Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy -- Molecular Mechanisms of Cardiovascular Damage Induced by Anti HER2 Therapies -- Cardiovascular Damage Induced by Radiotherapy -- Cardiovascular Damage Induced by Anti-VEGF Therapy -- Cardiovascular Damage Induced by Anti-BCR-ABL TKIs -- Heart Failure and Left Ventricular Dysfunction -- Coronary Artery Disease -- Peripheral Artery Disease and Stroke -- Valvular Heart Disease -- Arterial Hypertension -- Atrial Fibrillation in Cancer -- Management of QT Prolongation Induced by Anti-cancer Drugs -- Pulmonary Hypertension Induced by Anti-cancer Drugs -- Venous Thromboembolism -- Early Detection of Cardiac Damage -- Diagnosis of Cardiac Damage: Role of Stress Echo -- Early Detection and Monitoring of Vascular Damage -- Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need for Early Biomarkers and Cardio- and Vasculo-Protection in Personalized Therapy -- Cardiovascular Damage in Clinical Trials.

This book is designed to provide a useful and comprehensive resource and state-of-the-art overview to readers about cardiovascular damage potentially induced by antineoplastic drugs. Thanks to more and more effective antineoplastic treatments, the survival of cancer patients is increasing at an exponential rate. However, the burden of related cardiovascular complications that affect morbidity and mortality are also on the rise. A new branch of cardiology, Cardio-Oncology, was developed to combat this trend. The aim of its conception is to prevent cardiovascular complications related to cancer therapy and to facilitate and avoid interruption of antineoplastic drugs due to the occurrence of cardiovascular damage. The text focuses on cardiovascular complications related to cancer treatment and reviews the pathophysiological mechanisms leading to cardiovascular toxicity related to various antineoplastic drugs. Diagnostic modalities for early diagnosis are also discussed, followed by preventive and therapeutic strategies. Cardiovascular Complications in Cancer Therapy serves as a valuable resource for residents, fellow physicians, medical oncologists, cardiologists, and general practitioners and all those who take care of these patients.

ISBN: 9783319934020

Standard No.: 10.1007/978-3-319-93402-0doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Cardiovascular Complications in Cancer Therapy
LDR:03739nam a22004095i 4500 001 1012363
003 DE-He213
005 20200702084434.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783319934020 $9 978-3-319-93402-0
024 7 $a 10.1007/978-3-319-93402-0 $2 doi
035 $a 978-3-319-93402-0
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Cardiovascular Complications in Cancer Therapy $h [electronic resource] / $c edited by Antonio Russo, Giuseppina Novo, Patrizio Lancellotti, Antonio Giordano, Fausto J. Pinto.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2019.
300 $a XIII, 224 p. 41 illus., 38 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Clinical Pathology, $x 2197-781X
505 0 $a Introduction -- Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy -- Molecular Mechanisms of Cardiovascular Damage Induced by Anti HER2 Therapies -- Cardiovascular Damage Induced by Radiotherapy -- Cardiovascular Damage Induced by Anti-VEGF Therapy -- Cardiovascular Damage Induced by Anti-BCR-ABL TKIs -- Heart Failure and Left Ventricular Dysfunction -- Coronary Artery Disease -- Peripheral Artery Disease and Stroke -- Valvular Heart Disease -- Arterial Hypertension -- Atrial Fibrillation in Cancer -- Management of QT Prolongation Induced by Anti-cancer Drugs -- Pulmonary Hypertension Induced by Anti-cancer Drugs -- Venous Thromboembolism -- Early Detection of Cardiac Damage -- Diagnosis of Cardiac Damage: Role of Stress Echo -- Early Detection and Monitoring of Vascular Damage -- Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need for Early Biomarkers and Cardio- and Vasculo-Protection in Personalized Therapy -- Cardiovascular Damage in Clinical Trials.
520 $a This book is designed to provide a useful and comprehensive resource and state-of-the-art overview to readers about cardiovascular damage potentially induced by antineoplastic drugs. Thanks to more and more effective antineoplastic treatments, the survival of cancer patients is increasing at an exponential rate. However, the burden of related cardiovascular complications that affect morbidity and mortality are also on the rise. A new branch of cardiology, Cardio-Oncology, was developed to combat this trend. The aim of its conception is to prevent cardiovascular complications related to cancer therapy and to facilitate and avoid interruption of antineoplastic drugs due to the occurrence of cardiovascular damage. The text focuses on cardiovascular complications related to cancer treatment and reviews the pathophysiological mechanisms leading to cardiovascular toxicity related to various antineoplastic drugs. Diagnostic modalities for early diagnosis are also discussed, followed by preventive and therapeutic strategies. Cardiovascular Complications in Cancer Therapy serves as a valuable resource for residents, fellow physicians, medical oncologists, cardiologists, and general practitioners and all those who take care of these patients.
650 0 $a Oncology . $3 1253469
650 0 $a Cardiology. $3 593957
650 1 4 $a Oncology. $3 593951
700 1 $a Russo, Antonio. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 889000
700 1 $a Novo, Giuseppina. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1306618
700 1 $a Lancellotti, Patrizio. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064475
700 1 $a Giordano, Antonio. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1110704
700 1 $a Pinto, Fausto J. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1306619
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319934013
776 0 8 $i Printed edition: $z 9783319934037
776 0 8 $i Printed edition: $z 9783030066536
830 0 $a Current Clinical Pathology, $x 2197-781X $3 1254599
856 4 0 $u https://doi.org/10.1007/978-3-319-93402-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)